Clinical trial · Observational
Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)
Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis
NCT06481332CI-TRIAL-00078432CASTETTEunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of Event free survival in patients with triple-negative thrombocytosis
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myeloproliferative Neoplasm | Myeloproliferative Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Event-free survival
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with non reactive thrombocytosis for at least 6 months * availability of bone marrow biopsy and NGS panel Exclusion Criteria: * Unable to consent
References
Publications (0)
Data not yet available
No reference posted for this study.